{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:49:50Z","timestamp":1791330590047,"version":"4.3.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015825","name":"Korea University Anam Hospital","doi-asserted-by":"publisher","award":["O2412321"],"award-info":[{"award-number":["O2412321"]}],"id":[{"id":"10.13039\/501100015825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015825","name":"Korea University Anam Hospital","doi-asserted-by":"publisher","award":["K2513591"],"award-info":[{"award-number":["K2513591"]}],"id":[{"id":"10.13039\/501100015825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2025-02243104"],"award-info":[{"award-number":["RS-2025-02243104"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tamoxifen is widely used in breast cancer treatment, but its effects on vaginal microbiome remain poorly understood. This prospective longitudinal pilot study explored vaginal microbiota profiles and quality-of-life parameters in women receiving tamoxifen for breast cancer in Seoul, South Korea (2023\u20132024). Eleven women initiating tamoxifen therapy were enrolled. Vaginal swabs were collected at baseline (V0) and 6 months (V6). Microbiota was profiled using 16\u00a0S rRNA gene sequencing. Quality of life was assessed using the 11-item Menopause Rating Scale. Participants were stratified by baseline colonization patterns. Overall community composition did not show a significant shift between baseline and 6 months. In the full-cohort taxa-level paired analysis,\n                    <jats:italic>Gardnerella vaginalis<\/jats:italic>\n                    (\n                    <jats:italic>G. vaginalis<\/jats:italic>\n                    ) showed a nominal, non-FDR-significant increase from baseline to 6 months, and no taxon remained significant after multiple-comparison correction. A negative correlation was observed between\n                    <jats:italic>G. vaginalis<\/jats:italic>\n                    and\n                    <jats:italic>Lactobacillus iners<\/jats:italic>\n                    (\n                    <jats:italic>L. iners<\/jats:italic>\n                    ) (\u03c1 = \u22120.6, raw\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.01, FDR q\u2009&lt;\u20090.05). Among participants with baseline\n                    <jats:italic>G. vaginalis<\/jats:italic>\n                    detection, 4 of 5 showed increased relative abundance at 6 months, although the confidence interval was wide.\n                    <jats:italic>G. vaginalis<\/jats:italic>\n                    abundance was associated with worse sexual-function-related quality-of-life scores in exploratory analyses, but item-level MRS comparisons did not remain significant after correction for multiple testing. In this small hypothesis-generating pilot cohort, women receiving tamoxifen showed largely stable overall vaginal community composition over 6 months, with an exploratory signal of\n                    <jats:italic>G. vaginalis<\/jats:italic>\n                    expansion among participants colonized at baseline. These findings should be interpreted cautiously given the small sample size, absence of a control group, treatment heterogeneity, and post hoc subgroup analysis, and require validation in larger controlled cohorts.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-59886-w","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:33:43Z","timestamp":1783413223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal vaginal microbiomes and quality-of-life patterns during tamoxifen therapy in breast cancer: a pilot study"],"prefix":"10.1038","volume":"16","author":[{"given":"Hye Gyeong","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Jin","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjae","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungjin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Tae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"59886_CR1","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim, J. et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat. Med. 31, 1154\u20131162. https:\/\/doi.org\/10.1038\/s41591-025-03502-3 (2025).","journal-title":"Nat. Med."},{"key":"59886_CR2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3322\/caac.21863","volume":"74","author":"AN Giaquinto","year":"2024","unstructured":"Giaquinto, A. N. et al. Breast cancer statistics 2024. CA Cancer J. Clin. 74, 477\u2013495. https:\/\/doi.org\/10.3322\/caac.21863 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"59886_CR3","doi-asserted-by":"publisher","first-page":"e303","DOI":"10.1016\/s1470-2045(20)30666-5","volume":"22","author":"MA Franzoi","year":"2021","unstructured":"Franzoi, M. A. et al. Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer. Lancet Oncol. 22, e303\u2013e313. https:\/\/doi.org\/10.1016\/s1470-2045(20)30666-5 (2021).","journal-title":"Lancet Oncol."},{"key":"59886_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41586-019-1238-8","volume":"569","author":"Integrative HMP (iHMP) Research Network Consortium","year":"2019","unstructured":"Integrative HMP (iHMP) Research Network Consortium. The Integrative Human Microbiome Project. Nature 569, 641\u2013648. https:\/\/doi.org\/10.1038\/s41586-019-1238-8 (2019).","journal-title":"Nature"},{"key":"59886_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41564-022-01083-2","volume":"7","author":"M France","year":"2022","unstructured":"France, M., Alizadeh, M., Brown, S., Ma, B. & Ravel, J. Towards a deeper understanding of the vaginal microbiota. Nat. Microbiol. 7, 367\u2013378. https:\/\/doi.org\/10.1038\/s41564-022-01083-2 (2022).","journal-title":"Nat. Microbiol."},{"key":"59886_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41522-021-00259-8","volume":"7","author":"P \u0141aniewski","year":"2021","unstructured":"\u0141aniewski, P. & Herbst-Kralovetz, M. M. Bacterial vaginosis and health-associated bacteria modulate the immunometabolic landscape in 3D model of human cervix. NPJ Biofilms Microbiomes. 7, 88. https:\/\/doi.org\/10.1038\/s41522-021-00259-8 (2021).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"59886_CR7","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1097\/01.AOG.0000450757.18294.cf","volume":"601","author":"Committee on Gynecologic Practice. Committee Opinion No","year":"2014","unstructured":"Committee on Gynecologic Practice. Committee Opinion No. Tamoxifen and uterine cancer. Obstet. Gynecol. 123. 601, 1394\u20131397. https:\/\/doi.org\/10.1097\/01.AOG.0000450757.18294.cf (2014).","journal-title":"Obstet. Gynecol. 123"},{"key":"59886_CR8","doi-asserted-by":"publisher","first-page":"e2243951","DOI":"10.1001\/jamanetworkopen.2022.43951","volume":"5","author":"KJ Ryu","year":"2022","unstructured":"Ryu, K. J. et al. Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer After Tamoxifen Treatment in Premenopausal Women With Breast Cancer. JAMA Netw. Open. 5, e2243951. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.43951 (2022).","journal-title":"JAMA Netw. Open."},{"key":"59886_CR9","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/sj.bjc.6600294","volume":"86","author":"MJ Mourits","year":"2002","unstructured":"Mourits, M. J. et al. Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy. Br. J. Cancer. 86, 1546\u20131550. https:\/\/doi.org\/10.1038\/sj.bjc.6600294 (2002).","journal-title":"Br. J. Cancer"},{"key":"59886_CR10","doi-asserted-by":"publisher","unstructured":"Brown, T. A. 2nd et al. Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence. Breast Cancer Res. Treat. 181, 391\u2013401, (2020). https:\/\/doi.org\/10.1007\/s10549-020-05638-x","DOI":"10.1007\/s10549-020-05638-x"},{"key":"59886_CR11","doi-asserted-by":"publisher","first-page":"7417","DOI":"10.1038\/s41598-024-58118-3","volume":"14","author":"P Prasanchit","year":"2024","unstructured":"Prasanchit, P., Pongchaikul, P., Lertsittichai, P., Tantitham, C. & Manonai, J. Vaginal microbiomes of breast cancer survivors treated with aromatase inhibitors with and without vulvovaginal symptoms. Sci. Rep. 14, 7417. https:\/\/doi.org\/10.1038\/s41598-024-58118-3 (2024).","journal-title":"Sci. Rep."},{"key":"59886_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 10\u201312 (2011).","journal-title":"EMBnet J."},{"key":"59886_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods. 13, 581\u2013583. https:\/\/doi.org\/10.1038\/nmeth.3869 (2016).","journal-title":"Nat. Methods"},{"key":"59886_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods. 7, 335\u2013336. https:\/\/doi.org\/10.1038\/nmeth.f.303 (2010).","journal-title":"Nat. Methods"},{"key":"59886_CR15","doi-asserted-by":"publisher","first-page":"D243","DOI":"10.1093\/nar\/gkae1038","volume":"53","author":"T Goldfarb","year":"2025","unstructured":"Goldfarb, T. et al. NCBI RefSeq: reference sequence standards through 25 years of curation and annotation. Nucleic Acids Res. 53, D243\u2013d257. https:\/\/doi.org\/10.1093\/nar\/gkae1038 (2025).","journal-title":"Nucleic Acids Res."},{"key":"59886_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","volume":"38","author":"GM Douglas","year":"2020","unstructured":"Douglas, G. M. et al. PICRUSt2 for prediction of metagenome functions. Nat. Biotechnol. 38, 685\u2013688. https:\/\/doi.org\/10.1038\/s41587-020-0548-6 (2020).","journal-title":"Nat. Biotechnol."},{"key":"59886_CR17","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.7150\/ijms.6304","volume":"10","author":"J Castro","year":"2013","unstructured":"Castro, J. et al. Reciprocal interference between Lactobacillus spp. and Gardnerella vaginalis on initial adherence to epithelial cells. Int. J. Med. Sci. 10, 1193\u20131198. https:\/\/doi.org\/10.7150\/ijms.6304 (2013).","journal-title":"Int. J. Med. Sci."},{"key":"59886_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1472-6874-6-14","volume":"6","author":"NN Kim","year":"2006","unstructured":"Kim, N. N. et al. Effects of tamoxifen on vaginal blood flow and epithelial morphology in the rat. BMC Womens Health. 6, 14. https:\/\/doi.org\/10.1186\/1472-6874-6-14 (2006).","journal-title":"BMC Womens Health"},{"key":"59886_CR19","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1111\/jcmm.14851","volume":"24","author":"S Huang","year":"2020","unstructured":"Huang, S. et al. Tamoxifen inhibits cell proliferation by impaired glucose metabolism in gallbladder cancer. J. Cell. Mol. Med. 24, 1599\u20131613. https:\/\/doi.org\/10.1111\/jcmm.14851 (2020).","journal-title":"J. Cell. Mol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59886-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59886-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59886-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:49:45Z","timestamp":1791326985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59886-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59886"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59886-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current study was approved by the [Korea University Anam Hospital] Institutional Review Boards (#2022AN0424) and all participants provided written informed consent.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31181"}}